Found 0 matching trials
A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
PHASE2A multicenter randomized, single blind, active comparator controlled phase ...
Location
Renal Rheumatology and Immunology department Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Nutrient Timing in Connection to Evening Exercise
NAPhysical exercise (PE) significantly influences insulin sensitivity (IS), g...
Location
Department of Food and Nutrition, and Sport Science, Centre for Health and Performance, University of Gothenburg, Gothenburg, Sweden
Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19
PHASE1The purpose of this double-blind, randomized, controlled study is to assess...
Location
Xiangcheng Center for Disease Control and Prevention
Phase I Clinical Study of Recombinant Novel Coronavirus Vaccine
PHASE1In this trial, a total of 50 subjects were recruited; the test vaccines wer...
Location
The Second Affiliated Hospital of Chongqing Medical University
Phase III Clinical Trial of the Recombinant Respiratory Syncytial Virus Vaccine ( CHO Cell)
PHASE3This study will evaluate the efficacy of the Recombinant RSV vaccine(CHO ce...
Location
Guangdong Provincial Center for Disease Control and Prevention
The Phase Ⅱ/Ⅲ Trial of LYB001
PHASE2The study will be conducted in two phases using a randomized, double-blind,...
Location
Multiple Locations
A Study to Evaluate the Safety of Recombinant Herpes Zoster Vaccine for Healthy Individuals
PHASE1The purpose of this clinical study is to evaluate the safety and immunogeni...
Location
Hubei Provincial Center for Disease Control and Prevention
Bioavailability of the Polyphenols Contained in a Red Grape Extract-based Drink and Their Metabolic Effects
NARandomized placebo-controlled crossover study during which participants und...
Location
Multiple Locations
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
PHASE1This is a phase I, randomized, placebo-controlled, double-blind study, to e...
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Treatments Being Tested
Two doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14Three doses of middle-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28Two doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14Three doses of high-dose recombinant SARS-CoV-2 vaccine (CHO Cell) at the schedule of day 0, 14, 28Two doses of placebo at the schedule of day 0, 14 #middle-dose group#Three doses of placebo at the schedule of day 0, 14, 28 #middle-dose group#Two doses of placebo at the schedule of day 0, 14 #High-dose group#Three doses of placebo at the schedule of day 0, 14, 28 #High-dose group# Safety and Immunogenicity Study of Revaccination With SCB-1019T in Healthy Adults
PHASE1CLO-SCB-1019-002 is the first study of SCB-1019T vaccine for revaccination ...